Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

The Medicines Company

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.

The Medicines Company

Deal Watch May 2016

Deal Watch May 2016 The CRL refers to a manufacturing issue. ZS-9 was acquired when the company purchased ZS Pharma for $2.7bn. ... 911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

The Medicines Company appoints Biogen's Tony Kingsley

The Medicines Company appoints Biogen's Tony Kingsley He will be the New Jersey firm's president and COO. Biogen's Tony Kingsley has moved to The Medicines Company to take up the role of chief operating officer, where ... Clive Meanwell, chief executive officer of The Medicines Company, said: “Tony brings

Rare disease therapies head the ‘class of 2015’

Rare disease therapies head the ‘class of 2015’ One contributory factor could be the FDA's efforts to accelerate the review times for new medicines in order to get them to patients more quickly. ... cangrelor. Kengrexal. percutaneous coronary intervention (PCI). P2Y12 inhibitor. The Medicines Company.

Glenn Sblendorio to retire as president of The Medicines Company

Glenn Sblendorio to retire as president of The Medicines Company Sblendorio was appointed as a director at The Medicines Company in July 2011 and has served in his current roles since February 2012. ... Meanwell said: “Glenn has supported The Medicines Company for more than 14 years and he has been and remains my

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS

Alnylam predicts big things for its PCSK9 inhibitor ALN-PCS The company has previously indicated that even a once-monthly dosing would give it a "highly competitive position" versus current PCSK9 inhibitors, which are predicted to quickly become blockbuster drugs thanks ... The success in the ongoing phase I

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...